Virovance

Korvionix is an emerging life sciences technology company focused on improving the success rate of antibody therapeutics in oncology. The company is developing AI-enabled tools to predict how biologics distribute and act within solid tumors, helping partners prioritize candidates with the highest likelihood of clinical success. Korvionix supports early discovery through translational decision-making and collaborative development models.